Stroke Trial, Recruiting NCT06987682 Sponsor: University Health Network, Toronto Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06987682
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who were diagnosed with a stroke affecting the middle cerebral artery more than one year ago
  • People who are living in the community (not in a long-term care facility or hospital)
  • People who are able to stand on their own for at least 60 seconds without assistance
  • People who are able to understand spoken English

Who may not be able to join:

  • People who have a condition other than stroke that significantly affects their balance or posture (for example, an inner ear disorder or significant vision loss)
  • People who have previously had a bone fracture in the leg related to fragile or weakened bones
  • People who have a planned injection of Botox into the legs during the study period
  • People who have nerve damage in the legs
  • People who have certain conditions that make electrical stimulation unsafe — including an implanted electronic device (such as a pacemaker), active cancer or radiation treatment in the past six months, uncontrolled epilepsy, a skin rash or wound where the electrodes would be placed, current pregnancy, or an active blood clot in a deep vein
  • People who have conditions that make a brain stimulation technique called TMS unsafe — including a history of seizures or metal implants in the head
  • People who have taken part in a specific type of spinal stimulation treatment (tSCS) within the past two years (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416-597-3422

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 May 2025
Est. completion
1 June 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Mini-Balance Evaluation Systems Test; Spinal excitability for the tibialis anterior, soleus, biceps femoris and rectus femoris; Corticospinal excitability of the affected soleus and tibialis anterior; Gait and standing spatiotemporal data; Activities-specific Balance Confidence (ABC) Scale; Lean-and-Release Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov